Sheridan Capital Partners Invests in Atlantic Vision Partners

By

CHICAGO—Sheridan Capital Partners announced its investment in Atlantic Vision Partners (AVP), a vision practice management company. In the transaction, Sheridan invested alongside AVP’s founders and management, who will retain “a meaningful ownership stake” in the business, according to the announcement. “AVP has achieved meaningful scale in its geography,” said Jonathan Lewis, partner of Sheridan Capital Partners. “The company has grown significantly due to the team’s focus on clinical excellence and its ability to attract strong provider talent to the platform.”

Michael Holton, chief executive officer of AVP, remarked, “We believe Sheridan represents the perfect partner for us given their history in this kind of setting. The investment team has extensive experience building leading physician practice management businesses, and we look forward to growing AVP together with our team of doctors and managers.”

The transaction was led by Jonathan Lewis, Sean Dempsey, Alex Kain, and Matt Hinshaw at Sheridan Capital Partners. Twin Brook Capital Partners provided debt financing for the transaction. McGuireWoods LLP served as legal counsel to Sheridan Capital Partners. Terms of the transaction were not disclosed.

Atlantic Vision Partners is a vision practice management company, providing ophthalmic, optometric, and optical services throughout southern and central Virginia. The original AVP practice was founded by David Harman, MD, in 1988 and has grown from a single location with one physician to one of the largest eyecare practices in the state.

Sheridan Capital Partners is a Chicago-based health care private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada.